About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Luc Montagnier Is Not Losing It. Luc Montagnier Has Lost It. | Main | 500,000 Excess Deaths From Vioxx? Where? »

May 30, 2012

Please Fund Them So They Can Fund Us

Email This Entry

Posted by Derek

ChemJobber catches a very odd situation, as reported in C&E News. An official at a large R&D organization testifies to Congress about the importance of research funding. No surprises, eh? But get this: it's a VP of Corporate Alliances at WuXi.

Although, actually, it makes perfect sense. The more research funding there is in the U.S., the more contracting work there might be for WuXi, to make those dollars stretch further. Sensible or not, though, it does look strange.

Comments (5) + TrackBacks (0) | Category: Business and Markets


1. WuXi Apptech on May 30, 2012 12:13 PM writes...

I take it that the lack of comments mean that you agree............I want your jobs!!!!!!!

Permalink to Comment

2. MoMo on May 30, 2012 3:52 PM writes...

You already took away jobs from Americans, but I notice from my collaborators they are dissatisfied with your perfomrance! So they are coming back! Enjoy the downward spiral!

Your Chemistry Needs Us More Than We Need You!

Again Congress is commiting High-Treason, who were these Politicians?

Let's send them a Love-Letter!

Permalink to Comment

3. anonymous on May 30, 2012 7:42 PM writes...

So then it is true that the members of the US Congress are either: 1. complete idiots and devoid of any sense of reality viz a viz what is happening to the "highly skilled" science-related employment sector in the the US or 2. they have a FABULOUS sense of IRONY.

Your choice

Permalink to Comment

4. Anonymous on May 31, 2012 3:26 AM writes...

I'm going with #1.....

Permalink to Comment

5. TX raven on May 31, 2012 7:50 AM writes...

Let us not blame WuXi.
Who is making the decision to conduct lower quality med chem work in their labs?

I wonder, anyone out there working for a med chem group that strategically decided to stay in-house?

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry